Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion

被引:0
作者
Kevin F. Bieniek
Melissa E. Murray
Nicola J. Rutherford
Monica Castanedes-Casey
Mariely DeJesus-Hernandez
Amanda M. Liesinger
Matthew C. Baker
Kevin B. Boylan
Rosa Rademakers
Dennis W. Dickson
机构
[1] Mayo Clinic,Department of Neuroscience
[2] Mayo Clinic,Department of Neurology
来源
Acta Neuropathologica | 2013年 / 125卷
关键词
Frontotemporal lobar degeneration; C9ORF72; Ubiquitin; P62; Ubiquilin-2; Tau;
D O I
暂无
中图分类号
学科分类号
摘要
An expanded GGGGCC hexanucleotide repeat in C9ORF72 is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal lobar degeneration associated with TDP-43 pathology (FTLD-TDP). In addition to TDP-43-positive neuronal and glial inclusions, C9ORF72-linked FTLD-TDP has characteristic TDP-43-negative neuronal cytoplasmic and intranuclear inclusions as well as dystrophic neurites in the hippocampus and cerebellum. These lesions are immunopositive for ubiquitin and ubiquitin-binding proteins, such as sequestosome-1/p62 and ubiquilin-2. Studies examining the frequency of the C9ORF72 mutation in clinically probable Alzheimer’s disease (AD) have found a small proportion of AD cases with the mutation. This prompted us to systematically explore the frequency of Alzheimer-type pathology in a series of 17 FTLD-TDP cases with mutations in C9ORF72 (FTLD-C9ORF72). We identified four cases with sufficient Alzheimer-type pathology to meet criteria for intermediate-to-high-likelihood AD. We compared AD pathology in the 17 FTLD-C9ORF72 to 13 cases of FTLD-TDP linked to mutations in the gene for progranulin (FTLD-GRN) and 36 cases of sporadic FTLD (sFTLD). FTLD-C9ORF72 cases had higher Braak neurofibrillary tangle stage than FTLD-GRN. Increased tau pathology in FTLD-C9ORF72 was assessed with thioflavin-S fluorescent microscopy-based neurofibrillary tangle counts and with image analysis of tau burden in temporal cortex and hippocampus. FTLD-C9ORF72 had significantly more neurofibrillary tangles and higher tau burden compared with FTLD-GRN. The differences were most marked in limbic regions. On the other hand, sFTLD and FTLD-C9ORF72 had a similar burden of tau pathology. These results suggest FTLD-C9ORF72 has increased propensity for tau pathology compared to FTLD-GRN, but not sFTLD. The accumulation of tau as well as lesions immunoreactive for ubiquitin and ubiquitin-binding proteins (p62 and ubiquilin-2) suggests that mutations in C9ORF72 may involve disrupted protein degradation that favors accumulation of multiple different proteins.
引用
收藏
页码:289 / 302
页数:13
相关论文
共 160 条
[21]  
Brettschneider J(1997)Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease J Neuropathol Exp Neurol 56 1095-1097
[22]  
Van Deerlin VM(2008)Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease Acta Neuropathol 115 427-436
[23]  
Robinson JL(2009)Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes Acta Neuropathol 118 349-358
[24]  
Cairns NJ(2004)Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration Arch Neurol 61 1579-1584
[25]  
Bigio EH(2008)Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype Neurology 70 1850-1857
[26]  
Mackenzie IR(2009)Prominent phenotypic variability associated with mutations in Progranulin Neurobiol Aging 30 739-751
[27]  
Dai RM(1985)Diagnosis of Alzheimer’s disease Arch Neurol 42 1097-1105
[28]  
Li CC(2001)Ubiquitin-binding protein p62 is present in neuronal and glial inclusions in human tauopathies and synucleinopathies NeuroReport 12 2085-2090
[29]  
DeJesus-Hernandez M(2002)Early accumulation of p62 in neurofibrillary tangles in Alzheimer’s disease: possible role in tangle formation Neuropathol Appl Neurobiol 28 228-237
[30]  
Mackenzie IR(1998)Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22 Neurology 50 1546-1555